Actively Recruiting
Phase II Open-Label Study Evaluating Safety and Effects of MNV-201 Cell Therapy in Children With Pearson Syndrome
Led by Minovia Therapeutics Ltd. · Updated on 2026-10-13
6
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and therapeutic effects of a single intravenous infusion of autologous CD34 cells enriched with allogeneic placenta-derived mitochondria in children diagnosed with Pearson Syndrome, a type of mitochondrial disease. This Phase II open-label study focuses on a novel cell therapy called MNV-201, developed using mitochondrial augmentation technology to potentially address the multi-organ impact of mitochondrial disorders. Participants receive one dose of MNV-201, which involves isolating their own CD34 hematopoietic stem and progenitor cells from peripheral blood after mobilization by leukapheresis. These cells are then enriched with healthy donor mitochondria from placental tissue, prepared under strict manufacturing conditions. This single-dose treatment is designed to assess safety and efficacy over an extended follow-up period. During the study, participants will be monitored for treatment-related adverse events for 12 months and changes in height standard deviation scores over 12 and 24 months. Kidney function will also be tracked using calculated glomerular filtration rate over 24 months. Parents or legal guardians provide informed consent and help ensure adherence to study visits and assessments, which include clinical evaluations and laboratory tests. The total study duration extends up to two years post-treatment to evaluate both safety and therapeutic effects.
CONDITIONS
Brief Title
Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)
Research Team
L
Lea Bensoussan, Msc
N
Natalie Yivgi Ohana, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here